Trial Profile
An Open-Label Prospective Trial to Explore the Tolerability, Safety and Efficacy of Flexibly-Dosed Paliperidone ER Among Treatment-Naive and Newly Diagnosed Patients With Schizophrenia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 01 Nov 2012
Price :
$35
*
At a glance
- Drugs Paliperidone (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 29 May 2012 New trial record